The largest review of papers for brain cancer that has spread from the lungs has found abnormalities in the brain cancer for which licensed drugs could be clinically trialed to find out if they could treat the disease. The ...
Nov 29, 2023
0
0
A new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its tracks.
Nov 27, 2023
0
87
A study conducted at the University of Turku, Finland, shows that plixorafenib, a new drug developed for treating melanoma and lung cancer, may also stop the progression of cutaneous squamous cell carcinoma.
Nov 22, 2023
0
56
For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and may benefit overall survival, according to a new ...
Nov 21, 2023
0
37
It has been uncertain how Mycobacterium tuberculosis deflects the immune response in humans, though evidence has pointed to host immunometabolism—the intrinsic link between metabolism in immune cells and their immune function. ...
Nov 20, 2023
0
30
A new understanding of lung cancer cells' "memories" suggests a new strategy for improving treatment, Memorial Sloan Kettering Cancer Center (MSK) researchers have found.
Nov 18, 2023
0
65
Researchers have revealed that the protein Toll-like receptor 7 (TLR7), usually associated with antiviral defense in the body, surprisingly, exacerbates lung conditions such as chronic obstructive pulmonary disease (COPD), ...
Nov 15, 2023
0
13
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all measures for two years ...
Nov 10, 2023
0
0
People with Down syndrome are more likely than the general population to develop serious respiratory infections. Often, symptoms are so severe that patients require hospitalization. As respiratory season moves in, researchers ...
Nov 9, 2023
0
0
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led ...
Nov 8, 2023
0
40
